Immunic Inc (NASDAQ: IMUX) is -35.42% lower on its value in year-to-date trading and has touched a low of $0.56 and a high of $2.11 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IMUX stock was last observed hovering at around $0.70 in the last trading session, with the day’s gains setting it 0.96%.
Currently trading at $1.66M, the stock is -6.90% and -22.49% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.28 million and changing 1277321% at the moment leaves the stock -37.26% off its SMA200. IMUX registered -28.96% loss for a year compared to 6-month loss of -28.96%. The firm has a 50-day simple moving average (SMA 50) of $0.91658 and a 200-day simple moving average (SMA200) of $1.132335.
The stock witnessed a -20.18% gain in the last 1 month and extending the period to 3 months gives it a -40.80%, and is -4.82% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.32% over the week and 11.73% over the month.
Immunic Inc (IMUX) has around 91 employees, a market worth around $68.07M and $0.00M in sales. Distance from 52-week low is 26.63% and -66.33% from its 52-week high.
The EPS is expected to grow by 28.99% this year
79.0 institutions hold shares in Immunic Inc (IMUX), with institutional investors hold 45.43% of the company’s shares. The shares outstanding are 95.82M, and float is at 92.55M with Short Float at 8.04%. Institutions hold 44.81% of the Float.
The top institutional shareholder in the company is BVF INC/IL with over 8.9 million shares valued at $9.88 million. The investor’s holdings represent 9.15 of the IMUX Shares outstanding. As of 2024-06-30, the second largest holder is AVIDITY PARTNERS MANAGEMENT LP with 8.9 million shares valued at $9.88 million to account for 9.15 of the shares outstanding. The other top investors are SOLEUS CAPITAL MANAGEMENT, L.P. which holds 7.29 million shares representing 7.4954 and valued at over $8.1 million, while JANUS HENDERSON GROUP PLC holds 7.2701 of the shares totaling 7.07 million with a market value of $7.96 million.
Immunic Inc (IMUX) Insider Activity
The most recent transaction is an insider purchase by Nash Duane, the company’s Executive Chairman. SEC filings show that Nash Duane bought 20,000 shares of the company’s common stock on Jun 13 ’25 at a price of $0.83 per share for a total of $16694.0. Following the purchase, the insider now owns 36032.0 shares.
Immunic Inc disclosed in a document filed with the SEC on Jun 05 ’25 that Tardio Jason (President and COO) bought a total of 12,512 shares of the company’s common stock. The trade occurred on Jun 05 ’25 and was made at $0.79 per share for $9884.0. Following the transaction, the insider now directly holds 12512.0 shares of the IMUX stock.
Still, SEC filings show that on Jun 04 ’25, Vitt Daniel (CEO and Director) acquired 15,000 shares at an average price of $0.77 for $11550.0. The insider now directly holds 29,000 shares of Immunic Inc (IMUX).
